NASDAQ:HSIC - Nasdaq - US8064071025 - Common Stock - Currency: USD
65.3
+0.84 (+1.3%)
The current stock price of HSIC is 65.3 USD. In the past month the price decreased by -1.94%. In the past year, price decreased by -3.66%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
MCK | MCKESSON CORP | 24.29 | 88.79B | ||
COR | CENCORA INC | 20.56 | 56.59B | ||
CAH | CARDINAL HEALTH INC | 18.69 | 36.12B | ||
AHCO | ADAPTHEALTH CORP | 14.63 | 1.18B | ||
OMI | OWENS & MINOR INC | 4.94 | 580.15M | ||
AHG | AKSO HEALTH GROUP | N/A | 542.60M | ||
WGRX | WELLGISTICS HEALTH INC | N/A | 231.65M | ||
ATPC | AGAPE ATP CORP | N/A | 99.02M | ||
COSM | COSMOS HEALTH INC | N/A | 12.28M | ||
VRAX | VIRAX BIOLABS GROUP LTD | N/A | 4.41M |
Henry Schein, Inc. engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners. The company is headquartered in Melville, New York and currently employs 25,000 full-time employees. Its segments consist of Global Distribution and Value-Added services, Global Specialty Services, and Global Technology. Global Distribution and Value-Added Services include the distribution to the global dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services. This segment also includes value-added services such as financial services, continuing education services, consulting and other services. This segment also markets and sells under its own brand, a portfolio of consumable merchandise. The Global Specialty Products includes the manufacturing, marketing and sales of dental implant and biomaterial products; and endodontic, orthodontic and orthopedic products and other healthcare-related products and services. Global Technology includes the development and distribution of practice management software, e-services, and other products.
HENRY SCHEIN INC
135 Duryea Rd
Melville NEW YORK 11747 US
CEO: Stanley M. Bergman
Employees: 25000
Phone: 16318435500
The current stock price of HSIC is 65.3 USD. The price increased by 1.3% in the last trading session.
The exchange symbol of HENRY SCHEIN INC is HSIC and it is listed on the Nasdaq exchange.
HSIC stock is listed on the Nasdaq exchange.
23 analysts have analysed HSIC and the average price target is 79.36 USD. This implies a price increase of 21.53% is expected in the next year compared to the current price of 65.3. Check the HENRY SCHEIN INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
HENRY SCHEIN INC (HSIC) has a market capitalization of 8.00B USD. This makes HSIC a Mid Cap stock.
HENRY SCHEIN INC (HSIC) currently has 25000 employees.
HENRY SCHEIN INC (HSIC) has a support level at 65.1 and a resistance level at 65.31. Check the full technical report for a detailed analysis of HSIC support and resistance levels.
The Revenue of HENRY SCHEIN INC (HSIC) is expected to grow by 1.87% in the next year. Check the estimates tab for more information on the HSIC EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
HSIC does not pay a dividend.
HENRY SCHEIN INC (HSIC) will report earnings on 2025-05-05, before the market open.
The PE ratio for HENRY SCHEIN INC (HSIC) is 13.78. This is based on the reported non-GAAP earnings per share of 4.74 and the current share price of 65.3 USD. Check the full fundamental report for a full analysis of the valuation metrics for HSIC.
The outstanding short interest for HENRY SCHEIN INC (HSIC) is 4.69% of its float. Check the ownership tab for more information on the HSIC short interest.
ChartMill assigns a fundamental rating of 5 / 10 to HSIC. HSIC has only an average score on both its financial health and profitability.
Over the last trailing twelve months HSIC reported a non-GAAP Earnings per Share(EPS) of 4.74. The EPS increased by 5.33% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 3.08% | ||
ROA | 3.82% | ||
ROE | 11.49% | ||
Debt/Equity | 0.73 |
ChartMill assigns a Buy % Consensus number of 74% to HSIC. The Buy consensus is the average rating of analysts ratings from 23 analysts.
For the next year, analysts expect an EPS growth of 4.7% and a revenue growth 1.87% for HSIC